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ABSTRACT 
Abnormal carbohydrate metabolism frequently first appears in women 
during pregnancy as a transient condition. This form of latent diabetes melli-
tus is termed gestational diabetes. Diabetes in pregnancy, either overt or 
gestational, poses an increased risk to both mother and fetus. Fortunately, 
such risks have been greatly reduced by advances in the treatment of this com-
plication. Obviously, the implementation and the effectiveness of special ante-
natal care is dependent on an accurate and early diagnosis. However, the 
identification of gestational diabetics is inherently difficult because these 
women frequently lack the clinical symptoms and signs associated with overt 
diabetes mellitus. 
The purpose of this study was to examine the effectiveness of a one-
hour blood sugar test as a method to detect gestational diabetes, and to compare 
its effectiveness to that of the more commonly used screening criteria - family 
history of diabetes, previous large infant, previous poor obstetrical history, 
and maternal obesity. In addition, maternal age and parity was examined to 
determine their usefulness in predicting the development of gestational dia-
betes. This retrospective study was based on an examination of the medical 
records of 630 women, 531 of whom were administered a one -hour blood 
sugar test in addition to being screened for gestational diabetes by traditional 
methods. Seven gestational diabetics were identified through the use of a 
one -hour glucose screening test, and five of these seven prenatal patients also 
. had traditional screening factors present. The remaining two patients repre-
senting 29 percent of the gestational diabetics were identified solely by the 
one -hour test. A maternal age of 25 years or more was the only other factor 
which demonstrated a significant association with gestational diabetes. Macro-
somia, which was not correlated with gestational diabetes, was however signi-
ficantly associated with maternal obesity, maternal weight gain of greater than 
30 pounds during the pregnancy, maternal age of 25 years or more, and a past 
history of large infants .. 
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CHAPTER I 
INTRODUCTION 
Diabetogenic Nature of Normal Pregnancy and Its 
Relationship to Gestational Diabetes 
Several factors in normal pregnancy are know to cause physiological 
alterations in carbohydrate metabolism, some of which are diabetogenic in 
nature. Two phenomena are particularly important. First, the fetus is an 
obligate glucose consumer '(Adam, 1971) and continually withdraws glucose, 
amino acids, and fatty acids (but not insulin) from the mother's circulation in 
order to fuel its own growth and development. Glucose demand by the fetus 
tends to increase during pregnancy. This is reflected in the fact that the 
maternal glucose uptake at term has increased from a nonpregnant rate of 
2 to 3 mg./kg./min. to 6 mg./kg./min. (Felig, 1977). Second, placental 
contrainsulin factors increase throughout pregnancy. These factors increase 
maternal resistance to insulin (Freinkel, Metzger, Nitzan, Hare, Shambaugh, 
Marshall, Surmacznska, & Nagel, 1972; Trayner, Welborn, Rubenstein, 
Fraser, 1967) and result in decreased peripheral utilization of glucose 
(Burt, 1960) and hyperlipidemia (Freinkel, 1964). These factors include 
estrogen Qavier, Gershberg, & Hulse, 1968; Frantz & Rabkin, 1965), human 
growth hormone (Catt, 1970), placental lactogen (Spellacy & Cohn, 1973) and 
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two sets of insulin degrading enzymes of placental origin (Posner, 1973). 
By the 24th to 28th week of ges~ation, a net antagonism to the action 
of circulating insulin results in a maternal pancreatic response of increased 
insulin secretion. This has been demonstrated by radioimmunossay for 
insulin and is most marked in the third trimester (Spellacy & Goetz, 1963). 
Hypertrophy and hyperplasia of the pancreas during pregnancy, primarily 
involving the insulin-producing beta ce1ls, anatomically confirms this response 
(Felig, 1977). 
Pregnancy can thus be viewed as a unique biological test of the func-
tional reserve of a woman I s beta -cells. Frienkel et a1. (1972) suggested that 
gestational diabetes, a form of latent diabetes mellitus which appears during 
pregnancy, develops because these cells are unable to maintain the increased 
insulin production which is demanded during pregnancy in order to maintain 
gestational glucose homeostasis .. Yen, Tsai, and Vela (1971) demonstrated 
that the development of hyperglycemia and the retardation of glucose disposi-
tion (K -value) in gestational diabetics were clearly related to delayed insulin 
release as well as to a defect in the quantity and quality of insulin secreted 
in response to an intravenous glucose tolerance test (IVGTT). At six to eight 
weeks postpartum, 'Yhen the diabetogenic influence of pregnancy was absent, 
they found that the inadequate initial insulin response persisted, but that 
glucose disposition had returned to the normal range. 
. ' 
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Complications Associated with Gestational Diabetes 
The perinatal and maternal risks associated with overt diabetes melli-
tus in pregnancy are well known. They include increased fetal wastage, 
perinatal mortality, preeclampsia, polyhydramnios, maternal diabetic 
instability, fetal malformations, large babies, neonatal respiratory distress, 
hypoglycemia, and prematurity. It is generally agreed that gestational dia-
betics have a greater tendency to suffer these complications than does the 
general population (Abell & Beischer, 1974). 
Increased fetal wastage has been shown to be significantly higher in 
women with abnormal glucose tolerance tests (Notelovitz, 1970; 0 'Sullivan, 
1970; O'Sullivan, Gellis, & Tenney, 1966). Also, investigators have reported 
perinatal losses of 20 to 50 percent during periods ranging from 5 to 12 years 
prior to a diagnosis of overt diabetes (Dandrow & 0 'Sullivan, 1966; Jackson, 
1952; Moss & Mulholland, 1951; Pedowitz & Shlevin, 1957) • 
Infants of gestational diabetics do show a higher rate of perinatal 
morbidity, particularly respiratory distress and hypoglycemia (Hadden & 
Harley, 1967; Haworth & Dilling, 1975; Velasco, Benjamin, & Gordon, 1966; 
Willenger, 1966). Pildes (1973) states that 10 to 20 percent of these infants 
suffer complications during the neonatal period. In a study examining the 
relationship between maternal glucose intolerance and neonatal blood 
glucose, Haworth and Dilling (1976) found hypoglycemia in 77 percent of 
infants of diabetic mothers compared to only 8 percent of infants of mothers 
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with minor degrees of glucose intolerance. There was no control group 
of mothers who had normal glucose tolerances. He also noted that the best 
predictor of neonatal hypoglycemia was the blood glucose level at two hours 
during an oral glucose tolerance test. 
Pehrson (1974), in an extensive review of the literature, cited many 
studies which have shown a higher than normal frequency of macrosomia 
among infants of diabetic mothers. However, several other factors, seem-
ingly unrelated to diabetes, are also associated with macrosomia. These 
include a genetic predisposition, increasing parity (McKeown & Gibson, 1951), 
obesity of the mother (O'Sullivan et al., 1966), am previous large babies 
(Stallone & Ziel, 1974). Farquhar (1971) pointed out that variations in the 
birth weights of siblings born to prediabetic females may well be due to 
cyclic exacerbations and remissions characteristic of this stage of the dis-
ease. Macrosomia is, of course, associated with a number of negative 
obstetrical sequelae including birth traumas to mother and infant, fetal mal-
presentation, dystocia, and cephalopelvic disproportion. 
It is not clear how serious is the risk of prematurity for infants of 
gestational diabetics. The rate of prematlirity for infants born to prediabetic 
mothers varies from 4 percent to about 17 percent for the various popula-
tions for which this statistic has been reported (Moss et al., 1951; Paton 
1948; Reis, de Costa, & Allweiss, 1950). However, in judging the signifi-
cance of these figures, one must bear in mind that 5 to 10 percent of all live 
births are premature (Greenhill & Friedman, 1974, p. 697). 
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The frequency of congenital malformations among infants of overt 
_ diabetic mothers appears to be higher than among those of nondiabetic 
mothers. Amankwah, Prentice, ancl Fleury (1977) found that 13.6 percent 
of babies born to 44 known gestational diabetics had congenital abnormalities. 
Wilkerson and O'Sullivan (1963) reported that the incidence of congenital 
malforlnations in the population of diabetics they studied was 7 percent for 
the combined Class A through Class C diabetics (White's Classification). 
They also found that the incidence of these malformations was directly 
proportional to the degree of control of the disease. For prediabetics, that 
is for women who have not yet demonstrated any abnormal glucose metabolism, 
the frequency of congenital malformations reported in the literature varies 
from 4 to 9 percent (Carrington, 1960; Hagbard & Svanborg, 1960).· On the 
other hand, Koller (1953) and Haworth and Dilling (1975) found no higher inci-
dence of malformations among babies born to women with gestational diabetes 
than among those born to women in their general populations. Some of the 
strongest evidence of a link between diabetes and malformations comes from 
a study conducted by Navarete, Rojas, Alger, and Paniagua (1970). They 
examined a group of 349 women who have previously delivered a malformed 
child and a control group of 100 women of similar age and parity. The first 
group was divided into three subgroups: I. Women who had delivered a mal-
formed child less than one year earlier; II. Women who had had a congenitally 
malformed child 1-12 years earlier; and III. Women delivered of a malformed 
child 13 -25 years previously. The control group was similarly subdivided 
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according to time since their first pregnancy. The investigators observed a 
high frequency of known diabetes among the women who had previously 
delivered a malformed child: 6.6%, 14.8%, and 34.3% in Groups I, II, and 
III, respectively. The tota I incidence of diabetes (known diabetics plus 
women with an abnormal glucose tolerance) was even higher in the three 
groups: 16.7%, 40.4%, and 53.1%, respectively. In the control group, only 
one known diabetic and three women with abnormal glucose tolerance tests 
were discovered. 
Dandrow and O'Sullivan (1966) reported a trend towards higher risk 
of preeclampsia and polyhydramnios among gestational diabetics. Unfortu-
nately, their sample size was too small for statistical analysis. Among 
prediabetics, Moss and Mulholland (1951) found 14.2 percent to have pre-
eclampsia. Lunnell (1966) also reported a relationship between preeclampsia 
and eclampsia, and decreased glucose tolerance, but it was not statistically 
significant after other complications of pregnancy were factored out. 
Apart from increasing the risks involved in a current pregnancy, ges-
tational diabetes increases the likelihood that a woman will later develop the 
permanent, overt form of the disease. In three followup studies of 5, 10, 
and 12 years duration, it was found that the percentages of gestational dia-
betics who later developed overt diabetes were 20, 30, and 60, respectively 
(Michal, Begneaud, & Weese, 1966; Notelovitz, 1970; O'Sullivan & Mahan, 
1964). 
Another long-term complication of diabetes during pregnancy affects 
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the child. In a followup study, Churchill, Berendes, and Nemore (1969) found 
that infants of mothers whose diabetes was uncontrolled or left untreated to 
the point of developing both acetonuria and hyperglycemia had significantly 
lower I.Q. 's than their peers at four years of age. Stehbens, Baker, and 
Kitchell (1977) reached similar conclusions from the results of their five 
year study. 
Fortunately, rigorous screening and improved medical management 
have brought about a steady reduction in mortality and morbidity rates and in 
the rate of congenital malformations associated with gestational diabetes 
(Adashi, Pinto, & Tyson, 1979; Pedersen, Molsted -Pedersen, & Anderson, 
1974). Among the management modalities used for gestational diabetics are 
diet, use of ins ulin as indicated, use of urinary estriols, amniocentesis, 
and, according to some authorities, elective delivery at or before 38 weeks 
(Bates, 1974; Drury, 1970; O'Sullivan, Mahan, Charles, & Dandrow, 1974). 
In particular, the maintenance of plasma glucose concentrations no greater 
than 100 mg/l00 ml throughout the pregnancy has been claimed by several 
investigators to reduce the risk to mother and child to a negligible level 
regardless of the severity of the disease (Gyves, Rodman, Little, Fanaroff, 
& Merkatz, 1977; Karlsson & Kjellmer, 1972; Tyson & Hock, 1976). This 
has also resulted in a reduction in the number of Caesarean sections (Abell 
& Beischer, 1974). This is apparently due, at least in part, to a reduction 
in the incidence of fetal macrosomia (Coustan & Lewis, 1978'; Gyves et al., 
1977). In fact, routine preterm delivery, with all its associated risks, is 
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no longe! considered by some physicians to be justified for well-managed 
gestational diabetics (Khojandi, Tsai, & Tyson, 1974; Stallone & ;Ziel, 1974). 
The importance of improved screening for glucose tolerance is readily 
apparent - only those gestational diabetics which are identified can benefit 
from progressive medical management. 
Diagnosis of Diabetes Mellitus in Pregnancy 
Estimation of blood sugar remains the sole criteria for early clinical 
identification of the diabetic state. This is generally accomplished by the 
administration of a three hour oral glucose tolerance test (OGTT). If two or 
more abnormal values are obtained, the diagnosis is made. Blood sugar 
studies following a glucose load have not, however, shown any clear -cut 
demarcation between pregnant nondiabetic and pregnant diabetic populations 
(Alford, Martin, & Pearson, 1971; O'Sullivan & Mahan, 1964). Thus, any 
diagnostic definition of gestational diabetes is somewhat arbitrary at its 
lower level of detection. 
It is known that pregnancy and the immediate puerperium significantly 
alter "normal" nonpregnant blood sugar values. In a random group of 163 
pregnant women, in which known diabetics were excluded, a three hour OGTT 
was administered periodically during their pregnancy and three to six weeks 
postpartum (O'Sullivan, 1970). The blood sugar values for the pregnant 
population, compared to those of a matched nonpregnant sample, revealed 
lower fasting values and elevated postglucose values at one, two, or three 
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hours. These findings demonstrate the need to establish OGTT values which 
would separate alterations in glucose tolerance normally associated with 
pregnancy from those associated with the development of diabetes in preg-
nancy. O'Sullivan (1970) then tested 752 sequentially registering prenatal 
patients with a three hour OGTT am followed them for up to 12 years to see 
who developed the disease. He defined four classes of OGTT results: 1) 
Negative Blood Glucose (levels up to one standard deviation above the mean); 
2) Test Level I (glucose levels between one and two standard deviations above 
the mean); 3) Test Level IT (glucose levels between two and three standard 
deviations above the mean); and 4) Test Level III (glucose levels greater than 
three standard deviations above the mean. Of the 164 patients who later 
developed diabetes, 0.7% had tested negative, 13.3% were in Level I, 29.1% 
in Level II, and,52.8 % were in Level III. O'Sullivan concluded that specific 
blood glucose levels in pregnancy were clearly related to later development 
of diabetes and proposed the use of Test Level II (with values rounded to the 
nearest 0.5) for the diagnosis of gestational diabetes. Test Level II was 
chosen as the diagnostic cut-off in order to minimize the economic problems 
associated with long-term care and the psychological ill effects to the many 
patients in Test Level I who would not develop diabetes. The blood sugar 
levels O'Sullivan has proposed as diagnostic of gestational diabetes have 
received wide acceptance (Abell & Beischer, 1974; Gyves et al., 1977; 
Khojandi et al., 1974) and are used in this study. 
Several other points concerning oral glucose tolerance tests during 
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pregnancy are pertinent. O'Sullivan (1970) contrasted the minimum values 
he recommends to be used to diagnose diabetes in pregnancy and. nonpregnant 
patients employing three hour OGTT. They are as follows: 
Nonpregnant Pregnant 
Fasting .value 100 mg/100 ml 90 mg/l00 ml 
One-hour value 170-160 mg/100 ml 165 mg/100 m1 
Two-hour value 120 mg/100 ml 145 mg/100 ml 
Three -hour value 110 mg/l00 ml 125 mg/l00 ml 
The above glucose values are for whole blood. When plasma is used, they 
should be increased by 14 percent (O'Sullivan & Kantor, 1963). Other factors 
which will increase the glucose value are hemolysis, low hematocrit, and 
high plasma protein concentration. 
There is no concensus concerning the optimal level of the glucose chal-
lenge - both 50 gm and 100 gm challenges are used. Some physicians place 
patients on a high carbohydrate diet for three days prior to the test, while 
others prefer patients to continue to eat normally. Wilkerson (1960) has 
shown that significant variations in carbohydrate intake above the minimum of 
50 gm per day had very little effect on OGrr results. Several investigators 
have demonstrated that the two-hour blood sugar value is the most predictive 
of an abnormal tolerance. Tests are evaluated in terms of sensitivity and 
specificity. "Sensitivity" is the percent of patients correctly identified by a 
test; "specificity" is the percent who are correctly excluded. Wilkerson and 
o 'Sullivan (1963) found the sensitivity of the two-hour value to be 95.8 percent 
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and its specificity to be 94.6 percent. Both 'Notelovitz (1970) and Hohe (1971) 
recommend using a two-hour GTT in preference to the full three-hour test 
since they found the two results almost identical and the two -hour test is 
more economical of both time and money. It should be noted here that the 
degree of abnormality in an OGTT at the time of diagnosis is not predictive 
of the pregnancy's outcome. Rather, the duration and the degree of metabolic 
derangement are the primary influences on fetal outcome. Obviously the 
earlier the diagnosis and commencement of treatment, the better the fetal 
outcome that can be expected. Therefore, it is recommended that women 
who seem likely to develop gestational diabetes (for example, those with a pre-
vious history of the disease) should be screened on the first prenatal visit. If 
the tests are negative, they should be repeated after the 28th week, which is 
when the diabetogenic effects of pregnancy begin to manifest themselves 
(Gyves et al., 1977; Khojandi et al., 1974). Tyson et ale (1976) found that 
80 percent of women retested had a positive OGTT later in their pregnancy. 
Drury (1970) pointed out that negative tests before the 36th week cannot rule 
out the diagnosis of gestational diabetes since the impairment of glucose 
tolerance is progressive with pregnancy. 
Finally, it may be pointed out that several investigators advocate an 
intravenous rather than an oral GTT for screening and diagnosing abnormal 
glucose tolerance (Baker & Hutchinson, 1968; Pehrson, 1974; Silverstone, 
Solomons, & Rubricius, 1963). Unfortunately, the OGTT and IVGTT fre-
quently give disparate results in the same individual (Garnet, Helsel, & 
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Piver, 1968; Ocampo, Coserin, & Quilligan, 1964; Singh & Arshat, 1978). 
The advocates of IVGTT object to the OGTT because changes in gastrointesti-
nal motility during pregnancy are known to interfere with the absorption of 
glucose. Since the IVGTT bypasses the gastrointestinal tract, it is claimed 
to more accurately test the insulin response of the pancreas to the glucose 
challenge. Garnet et al. (1968) claimed that the IVGTT is a more accurate 
means to identify milder forms of abnormal glucose metabolism. However, 
the evidence from their study does not support this assertion. In a six year 
prospective study, Hadden, Harley, Kajtar, and Montgomery (1971) compared 
the value of several tests in predicting fetal outcome. They compared a two-
hour OGTT, a Cortisone GTT, and an IVGTT, each administered at 32 weeks 
gestation. There was no clear difference among the tests. Benjamin and 
Casper (1967) conducted a study in which 144 patients were given both an OGTT 
and an IVGTT in the third trimester of pregnancy and again between six weeks 
and three months after delivery. They claim that the oral test is more spe-
cific. Their main objection to the IVGTT is that it produced a much higher 
rate of false negatives (47%) than did the OGTT (12%). However, these 
authors did note that the true relative and absolute reliability of these tests 
can only be determined by long-term prospective studies. No such studies 
were found in the literature. 
Controversy Regarding Screening Methods 
for Gestational Diabetes 
A complete glucose tolerance test for every patient several times 
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during pregnancy is the only means of detecting all gestational diabetics 
(MacAffee & Beischer, 1974) and h~s been recommended by some for all 
pregnant patients. However, the detection rate in a given population may not 
justify the laboratory and staffing costs involved." An incidence of only 0.7 
percent was found in an Australian population in which 2,000 consecutive 
patients received a three -hour OGTT (Abell & Beischer, 1975). Thus, there 
is a need to establish a method of screening which would identify most preg-
nant women at risk of abnormal glucose tolerance without requiring a com-
plete three-hour OGTT for all patients. 
The traditional method of screening for gestational diabetes has been 
to determine first the presence of certain clinical criteria (MacAffee et al., 
1974; Moss et al., 1949). If one or more are present, a three-hour OGrr is 
then ordered. These "classical" criteria include: I} family history of diabetes 
(sometimes limited to a first degree relative); 2} birth of a large baby (vari-
ously defined as greater than or equal to nine or to ten pounds); 3} poor past 
obstetrical history (which includes two or more unexplained abortions, still-
births, or neonatal deaths; premature birth, congenital malformations, 
history of proteinuria, hypertension, polyhydramnios, and excessive weight 
gain); 4} maternal obesity (usually defined as a prepregnant weight 20% or 
more over the ideal); and 5} glycosuria (occasionally limited to the second 
fasting urine specimen or a level greater than 1+ on two or more occasions). 
O'Sullivan (1961) screened 20,070 registered prenatal patients using these 
criteria alone and identified one gestational diabetic out of every 116 patients 
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- 0.86 percent of all women registering. Others report rates between 1 and 
2 perc"ent (Abell & Beischer, 1974; Chen, Palav, & Tricomi, 1972; Drury et 
al., 1970; Gyves, 1977). These traditional criteria, however, fall far short 
of the desired selectivity and specificity of a screening tool. Many investi-
gators have found no significant relationship between any single crite rion 
from the list of traditional screening factors and gestational diabetes. Only 
combinations of two or more criteria are associated with abnormal glucose 
tolerance and increased perinatal morbidity (Chen et al., 1972; Drury et al., 
1970; Granat et al., 1979; O'Sullivan, Charles, Mahan, & Dandrow, 1973). 
In addition, investigator s often must redefine a particular factor in a more 
limited way in order to report a meaningful association with gestational dia-
betes. For example, Soler and Malins (1971) limited "family history" to first 
degree relatives, and Granat et al. (1979) only found the history significant if 
the family member was a maternal sibling. The factor "glycosuria tf is acknowl-
edged to be the poorest of all the predictors. Drury et ale (1970) founds its 
specificity for glucose intolerance during pregnancy to be only 14.8 percent. 
Notelovitz (1970) reported the slightly higher figure of 18.4 percent but added 
that no fewer than 35 percent of known diabetics had no glycosuria. 
Two other factors which are sometimes claimed to be associated with 
gestational diabetes are increased parity and maternal age. One study was 
found which supported increased parity as an independent predictor of gesta-
tional diabetes (Chen et al., 1972); most researchers found no such association 
after correcting for maternal age (Granat et al., 1979; O'Sullivan et al., 1973). 
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In a five year study by O'Sullivan et al. (1973), the following were 
obtained from two groups of prenatal patients: 
A. A full clinical history which ascertained: 1) birth of a 
baby weighing nine pounds or more; 2) a history, in two 
or more pregnancies, of fetal death, neonatal death, con-
genital anomaly, prematurity, excessive weight gain, 
hypertension, or proteinuria; 3) a family history of dia-
betes' and 4) the mother's age. 
B. A one-hour screening blood sugar test following a 50 gm 
glucose challenge. 
Only known diabetics are excluded from this study. In the first group of 
18,812 patients, only those women whose blood sugar level at one-hour was 
equal to or greater than 130 mg per 100 ml of whole blood were scheduled for 
a three-hour OGTT. In the second group of 986 women, all patients were 
offered a three-hour OGTT and 76 percent responded. The one-hour screen-
ing. blood sugar tests were not significantly different between respondents and 
nonrespondents. The diagnosis of gestational diabetes was made from the 
three-hour OGTT using the previously discussed criteria (O'Sullivan, 1970). 
The sensitivity and specificity ratings were obtained and the screening blood 
sugar test and the more traditional screening factors were compared. The 
percentage of gestational diabetic patients correctly identified by the screen-
ing blood sugar test was 79 (sensitivity rate) compared to 63 percent for the 
traditional screening factors. The percent of patients who were correctly 
excluded by the screening blood sugar test (specificity rate) was 87. The 
specificity rate for the traditional screening factors was 56 percent. For 
the subpopulation of those patients 25 years or older, the sensitivity rating 
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of the blood sugar test was 88 p~rcent and the specificity was 82 percent. 
The sensitivity and specificity of the traditional test for this older subgroup 
were 69 percent and 35 percent respectively. 
Although they did not present the supporting data, O'Sullivan et ale 
(1973) claimed that maternal age is also an important screening factor for 
determining the presence of gestational diabetes. They considered older 
patients as those 25 years or older. This claim is supported by the findings 
of others (Granat et a1., 1979; Pehrson, 1974; Spellacy et al., 1977). but in 
these studies the age group at higher risk for carbohydrate intolerance was 30 
years and older. On the other hand, in three recent studies no relationship 
between maternal age and any untoward outcome of pregnancy was found 
(Adashi et al., 1979; Gabbe, Mestman, Freeman, Anderson, & Lowensohn, 
1977; Gyves et al., 1977). However, in these studies a strict medical regime 
to maintain euglycemia throughout the pregnancy was maintained and may 
account for the favorable outcomes for all age groups. Adashi et ale (1979) 
also found a higher incidence of infants which were large for gestational age 
among mothers over 25 years old. 
The recommendation of O'Sullivan et al. (1973) that a one-hour blood 
sugar test be used to screen for gestational diabetes was applied in a study 
by Amankwah et ale (1977). They administered a one-hour screening plasma 
glucose test after a 50 gm oral glucose load to 1, 184 prenatal patients between 
32 and 33 weeks gestation. All known diabetics were excluded. Of the 1, 184 
patients, 299 (25.3%) had positive screening tests and these received the 
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standard glucose tolerance test. Of these 299 patients, 71 (6%) were diag-
nosed as gestational diabetics. These investigators also pointed out that 57 • 6% 
were 25 years or older, 26.8% were obese, and 47 • 9% had a family history of 
diabetes. Sensitivity and specificity rates could not be computed since both 
a one-hour screening test as well as a three-hour OGTT had not been done 
on every patient. However, the authors did state that the glucose screening 
had markedly improved their yield of gestational diabetics and because of 
early, rigorous medical treatment, resulted in a marked improvement in 
pregnancy outcome. 
Statement of the Problem 
Since 1978 all prenatal patients of the Family Health Program of Utah 
are routinely given a one-hour glucose screening test for decreased glucose 
tolerance. All those with positive screening tests are then given a three-hour 
oral glucose tolerance test to rule out the diagnosis of gestational diabetes. 
The purpose of this retrospective study is to compare the number of gesta-
tional diabetics identified by a positive one -hour screening test to the number 
that would have been identified had this screening test been limited to those 
patients with the following traditional factors present. 
1. Family history of diabetes; 
2. previous large infant (weighing 9 lbs/4, 000 g or more); 
3. previous unexplained stillborn, neonatal death, prenature birth; 
4. previous pregnancy complicated by hypertension (systolic> 140 
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and/or diastolic ~ 90 at rest on two or more occasions), proteinuria (2+ 
on two or more occasions), excessive weight gain (greater than 30 pounds 
for pregnancy), polyhydramnios or preeclampsia (as diagnosed by physician 
or CNM in the record). 
Significance of This Study with Specific 
Reference to Nurse-Midwifery 
Detection of gestational diabetes is the first step in providing early 
medical and nursing interventions which will improve the outcome of this high-
risk pregnancy. Any research which could lead to an improvement in the 
screening process for this disease is thus of obvious medical worth and is of 
critical importance to the practice of nurse-midwifery. 
The results of this type of research can also contribute to the trend 
toward a more holistic approach in health care delivery. Until recently, the 
focus of medicine and, to a somewhat lesser extent, nursing has been on 
pathology. "The span of holistic medicine is far broader, including preven-
tion, life -style modification, psychological counseling, and supporting the 
patient as a responsible individual" (Pelletier, 1979, p. 38). The patient is 
invited to become an active participant and the primary source of positive 
change in his own health care. Such approaches are based on the principle 
that health is not the absence of disease. Rather, health care providers' must 
both promote and maintain the optimal level of wellness possible for the whole 
person --body, soul, and mind --as well as treat and prevent disease (Bruhn, 
Cordova, Williams, & Fuentes, 1977; Fink, 1976). 
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Commitment to holistic patient care is embedded in the practice of 
American nurse-midwifery, as the written philosophy, functions, and stan-
dards of the American College of Nursing demonstrate. The midwife is 
mandated to work toward a colloquial relationship with both her patient and 
other health care workers. As long as the mother and newborn remain essen-
tially healthy, a midwife is responsible for their management and complete 
care. However, of equal importance is the responsibility to be able to 
identify any deviations from the norm which would require immediate col-
laboration with a physician. Thus, research which aims to improve the 
identification of the high risk pregnant patient is especially helpful in improv-
ing this significant area of nurse -midwifery practice. 
CHAPTER II 
METHODS 
Study Site, Population, and Data Collection 
The Family Health Program of Utah (FHP), a branch of the Family 
Health Program of Southern California, is a staff model health maintenance 
organization which has two centers serving the greater Salt Lake City area. 
This nonhospital based, nonprofit corporation serves a broad spectrum of 
socioeconomic groups, although the typical patient is both middle-class and 
caucasian. The data for this study were gathered by reviewing the prenatal 
records of all women who both received their prenatal care and delivered their 
babies within the FHP health care system between May 1979 and April 1980. 
These women were identified by examining the delivery lists of the two FHP 
centers. When an infant's birthweight was not in the mother's chart the 
appropriate newborn pediatric record or hospital nursery record was also 
reviewed. 
In these clinics all prenatal patients were routinely to be given a one-
hour plasma glucose screening test at approximately 26 to 30 weeks gestation. 
Those with a positive one-hour screening test are then scheduled for a standard 
three-hour oral glucose tolerance test (OGTT). Patients were instructed to 
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consume a high carbohydrate diet for the three days just prior to either of 
< these tests and to fast from midnight the night before (See Appendix). Assays 
of plasma glucose were performed by the glucose hexokinase method using an 
Abbot VP Chemistry Analyzer (See Appendix). Only women known to be 
diabetics prior to their pregnancy were intentionally excluded from this study. 
Data Collected and Definition of Terms 
Positive One -hour Screening Test 
All women whose plasma glucose levels were 130 mg. II 00 ml. or 
greater one hour after a 50 g. oral glucose load were considered to have a 
positive one -hour screening test. 
Positive Three-hour Oral Glucose Tolerance Test 
Gestational diabetes was diagnosed when the result of a three -hour 
OGTT was positive. The test was considered positive if two or more of the 
following glucose levels were met or exceeded: 
Fasting value 
One ... hour value 
Two-hour value 
Three-hour value 
Traditional Screening Factors 
104 mg./100 ml. 
190 mg./100 ml. 
167 mg./IOO ml. 
138 mg./IOO ml. 
Family history of diabetes. It was determined from the patient's chart 
whether any family members suffer from diabetes mellitus. The number in 
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each of the following categories was recorded: Parents, Siblings, Grand-
parents, Other Relatives. 
Previous large infant. The number of previous babies whose birthweight 
equalled or exce~ded 4000 grams (c. 9 lbs.) was recorded. 
Poor obstetrical outcome. The reported numbers. of previous spon-
taneous abortions, stillborn, neonatal deaths, and premature births were 
recorded. 
Previous pregnancy complications. The number of previous pregnancies 
that were complicated by the following problems was recorded. 
1. Hypertension: systolic ) 140 and/or diastolic > 90 at rest 
on two or more occasions. 
2. Proteinuria: 2+ on two or more occasions. 
3. Polyhydramnios: as diagnosed by physician or C.N.M. in 
the record. 
4. Preeclampsia: as diagnosed by physician or C. N. M. in the 
record. 
Current Pregnancy Complications 
. 
It was noted whether the current pregnancy was complicated by any of 
the problems discussed above. 
Additional Data 
The following data were also collected by reviewing the patient's chart: 
rna ternal age, gravidity, prepregnancy weight, weight at time of delivery, height, 
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weight, and age (in weeks of gestation) of the infant at birth. The weight 
gained during pregnancy was computed from prepregnant weight and weight 
at time of delivery. 
Analysis 
The study population was categorized into subgroups for various parts 
of the analysis. These subgroups are: multigravous and primigravous women; 
those given and those not given one -hour screening tests; those with positive 
and those with negative one -hour tests; and gestational diabetic and nondiabetic 
mothers. 
Continuous variable~, such as birth weight and one-hour values of the 
screening test, were summarized by calculating means and standard devia-
tions. Differences in means between the various subgroups were tested for 
statistical significance using t-tests. 
Histories of diabetes in the family, previous large infant, poor 
obstetrical outcome, past pregnancy complications, and current pregnancy 
complications were treated as simply present or absent for the analysis. 
These and other discrete variables, such as parity, were summarized by 
computing frequency distributions. In order to determine whether there were 
any statistically significant associations between any of these variables or 
between these variables and those upon which the above subgroups are based, 
contingency tables were constructed and chi-square tests of independence 
were performed. Although percentages are generally reported for these 
attri~ute data, the chi -sq uare tests were performed on the counts. 
CHAPTER III 
RESULTS 
Description of the Study Population 
The prenatal population for this study consisted of 630 patients. 
Twenty-nine percent of these women were primigravidas and 71 percent were 
multigravidas. The salient characteristics of these two subgroups and of the 
total population are presented in Table 1. The average woman in this study 
was about 25 years old and had had two or three babies previously. About 15 
percent of the population was overweight at the beginning of their pregnancy. 
A large proportion (48%) gained more than 30 pounds during the course of 
their pregnancy. A larger proportion of the primigravidas gained excessive 
weight than did multigravidas (X2 = 4.10; df = 1;.E <.05). A significantly 
larger proportion of primigravidas also had pregnancy complications. This 
was entirely due to the higher incidence of preeclampsia among primigra-
vidas (18.1% vis a vis 2.2% for multigravidas). 
The mean birthweight of infants born to mothers in this study was 3417 
grams. Infants of multigravidous women were significantly heavier than the 
infants of primigravidous women (t = 2.34; df 262;..E < 0.05). Others have 
a Iso observed a direct relationship between infant birthweight and parity 
Table 1 
Characteristics of the Population of F. H. P. Clinic Patients 
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*The mean (standard deviation) or the percent having an attribute are tabulated. 
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(Romney, Gray, Little, Merrill," Quilligan, & Stander, 1975, p. 86). There 
was no significant difference between multigravidas and primigravidas in 
the proportion bearing infants larger than 4000 grams nor in the proportion 
giving birth to infants less than 2500 grams. 
There was no significant difference in the gestational age of infants 
born to multigravidas and. primigravidas. The mean gestational age of 
infants in the population was 39.5 weeks. 
Table 2 shows the distribution of patients with regard to the one -hour 
and three -hour glucose tolerance tests. One hundred women are missing 
from this portion of the study; 79 did not receive the one-hour screening test 
and 21 who had a positive screening test did not receive a three -hour OGTT. 
In order to check whether the women who did not receive a screening test 
were a nonrandom sample of the total population, they were compared to the 
subgroup who did receive the test. There were no significant differences 
between the two groups in age, gravidity, traditional screening factors, or 
current pregnancy problems. There was a significant difference in mean 
birthweight (t = -2.0; df= 77.2; P < .05) and in gestational age (t = 3.2; 
- -
df = 82; E. < .005). The infants of mothers who did not have the one-hour 
test averaged approximately 7 ounces lighter and were born about a week 
and a half earlier than those of mothers who had the test, although both 
mea.ns were within normal limits. There seems no reason to believe that 
the results based on the data from the subgroup who received a screening test 
cannot be generalized to the population as a whole. It should, however, be 
Table 2 
Distribution of Patients with Regard to One -hour Blood 
Sugar Screening Test and Three-hour OGTT 
No Negative Positive 
Patients with: 30 test 30 test 30 test 
No One -hour te st 78 1 a 
Negative One-hour test 432 3 a 
Positive One -hour test 21 88 7 
noted that two previously diagnosed gestational diabetics did not receive 
screening tests. 
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In many cases one could not determine from the charts why patients 
did not receive a screening test. However, in nearly half the cases patients 
who did not receive the one -hour test had a history of noncompliance, repeated 
missed prenatal visits, and/or late registration for prenatal care. In the 
case of the 21 patients who had a positive screening test but no three -hour 
OGTT, 7 did not comply with the request for the test, 2 could not tolerate the 
glucose load, and for 11 there was no documented reason for missing the test. 
Four patients were given a three-hour OGrr despite a negative or missing 
one-hour test. Of these one had a very high, though not positive, blood 
sugar value and was bearing twins, tWo were very positive in terms of tradi-
tional screening factors, and one had a "defect in her pituitary gland. It All 
four had negative three-hour GGTT's. 
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Fifty-nine percent of the study population were positive for one or 
more traditional screening factors. Since primigravidas have by definition 
no past obstetrical history, only a family history of diabetes, obesity, and 
possibly excessive weight gain are relevant traditional screening factors for 
them. There was no significant difference in the proportion of primigravidas 
and multigravidas who had a family history of diabetes. Of the traditional 
screening factors, a family history of diabetes was by far the most common 
for the whole population (42%), followed by poor obstetrical outcome (20%), 
history of previous large infant (10%), and poor obstetrical history (7%) 
(See Table 1). The distribution of the population relative to the traditional 
screening factors is shown in Table 3. Relatively few women were positive 
for more than two traditional screening factors. 
Table 3 
Proportion of the Study Population with Various Numbers 
of Traditional Screening Factors (TSF) 
Variable Primigravidas Multigravidas Total Group 
Only one TSF 38.5% 44.2% 34.0% 
One or more TSF* 38.5% 71.0% 59.4% 
Two or more TSP* 26.8% 25.4% 
Three or more TS P * 6.5% 7.2% 
Four TSF 1.6% 1.2% 
*This is a cummulative computation. 
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Effectiveness of the One -hour Glucose Screening Test 
The main objective of this study was to compare the number of gesta-
tional diabetics identified by a positive one -hour screening test to the number 
identified by a positive one -hour screening test and by the presence of one or 
more traditional screening factors. Only those patients who received both a 
positive one-hour screening test and the three-hour OGTT could be used for 
this comparison. Ninety -five patients so qualified. A review of their medical 
histories indicated whether one or more of the traditional screening factors 
were positive. The results of this analysis are presented in Table 4. Two 
out of the seven identified gestational diabetics would have been missed by the 
traditional ·screening test. 
Table 4 
Number of Gestational Diabetics Identified by a 
One -hour Screening Test or by a Screening 
Test and Traditional Pactors 
Negative Positive 
Three-hour OGTT Three-hour OGrr 
Positive One -hour Test 88 7 
Positive One-hour Test and One or More TSP* 64 5 
Positive One-hour Test and Two or More TSP* 24 4 
Positive One-hour Test and Three or More TSP* 5 0 
Positive One-hour Test and Pour TSP 1 0 
·This is a cummulative computation. 
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Comparison of Subgroups 
Since the ultimate goal of this type of research is to find the best 
means of identifying a small, difficult to detect group of women who are 
transiently afflicted with a serious disease, comparisons were made between 
several subgroups within the study population. The purpose of these compari-
sons was to determine if any of the variables measured in this study were 
associated with a positive one-hour screening test or a positive three-hour 
OGTT. 
Those with positive and those with negative one-hour screening tests 
were compared using the following variables: age, gravidity, obesity, exces-
sive weight gain, current pregnancy complications, and traditional screening 
factors. No significant differences were found except for age; a larger pro-
portion of patients 30 years old or older had positive one -hour tests than 
did younger patients (X2 = 8.43; df = 2; E. < .05) (See Table 5). 
Similar comparisons were made between those with a positive and 
those with a negative three-hour OGTT. No significant differences were 
found (See Table 6). 
Finally, the gestational diabetics were compared to the rest of the 
study populations (See Table 7). The only variable that differed significantly 
between the two populations was age. The mean age of the gestational dia-
betics was 28.7 years compared to 24.8 years for the rest of the study popu-
lation (t = 2.08; df = 628; E. < 0.05). The range for gestational diabetics 
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Table 5 
Comparison of Study Variables between Patients with a 
Positive One-hour Screening Test and Patients 
with a Negative One-hour Screening Test 
Negative Positive 
One-hour One-hour X2 df E. 
Patient < 30 years old 371 64 
Patient ~ 30 years old 85 31 8.43 1 < 0.05 
Primigravidas 164 36 
Multigravidas 271 80 1.48 1 ns 
Not obese 370 94 
Obese 61 19 0.316 1 ns 
No excessive weight gain 224 55 
Exces sive weight gain 208 61 0.55 1 ns 
No current pregnancy 
complications 370 98 
Current pregnancy 
complications 65 18 0.00 1 ns 
No TSF 174 35 
L- one TSF 261 81 3.35 1 ns 
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Table 6 
Comparison of Study Variables between Patients 
with a Positive Three -hour OaTT and Patients 
with a Negative Three-hour OaTT 
Negative Positive 
Three-hour Three-hour X2 df E. 
Patient < 25 years old 48 0 
Patient ~ 25 years old 44 7 5.155 1 (0.05 
Primigravidas 32 1 
Multigravidas 60 6 0.48 1 ns 
Not obese 75 4 
Obese 15 3 .23 1 ns 
No excessive weight gain 42 2 
Excessive weight gain 50 5 .23 1 ns 
No current pregnancy 
complications 42 2 
Current pregnancy 
complications 50 5 .63 1 ns 
No TSF 29 2 
) one TSF 62 5 0.03 1 ns 
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Table 7 
Comparison of Study Variables between Gestational 
Diabetics and Nondiabetic Prenatal Patients 
Gestational Nondiabetic X2 
Diabetic Patients or t df ~ 
Mean Maternal Age 28.7 24.6 t = 2.08 628 (0.05 
Primigravidas 1 224 
Multigravidas 6 399 X2=0.63 1 ns 
Not obese 4 520 
Obese 3 90 X2=2.36 1 ns 
No excessive weight gain 318 295 
Excessive weight gain 2 5 X2=0.72 1 ns 
No current pregnancy 
complications 7 531 
Current pregnancy 
X2=0.32 complications 0 92 1 ns 
No TSF 2 238 
> 1 TSF 5 385 X2=0.02 1 ns 
Infant < 4000 g 5 540 
Infant 2. 4000 g 2 74 X2=0.56 1 ns 
Mean gestational age 39.5 39.5 t = .08 628 ns 
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was 25 to 37 years. Of the six gestational diabetic mothers who gave birth 
to a single baby, two had an infant that weighed more than 4000 grams. This 
is a larger proportion of large infants than in the general population; how-
eve!", the chi-square test of independence was not significant. The sample 
size was quite small so one should probably be cautious about accepting the 
null hypothesis. \Vhat is statistically conservative is not necessarily cHni-
cally conservative. If large babies are associated with gestational diabetes, 
it is a cause for concern. 
Macrosomia 
No significant association was found between macrosomia and gravid-
ity, current pregnancy complications, the results of a one-hour screening 
test, the result of a three-hour OGTT or with three of the four traditional 
screening factors (poor obstetrical outcome, pregnancy complications, and 
family history of diabetes) (See Table 8). A significant association was found 
between macrosomia and increased maternal age (X2 = 7.02; df = 2, J? <.05), 
obesity (X2 = 8.91; df = 1; E. < . ODS), excessive weight gain (X2 = .22.4; df = 
1; E. < .001), a history of previous 'large infants (X2 = 22. 7; df = 1; P. <. DOl). 
Of all babies born to mothers 25 years old or older 16.3 percent weighed 
more than 4000 grams. Only 9.3 percent of mothers younger than 25 years 
gave birth to large infants. About one out of every five infants born to 
mothers who gained more than 30 pounds during pregnancy weighed more 
than 4000 grams, whereas only one out of 16 infants born to mothers who 
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Table 8 
Association between Macrosomia and Various Other Factors 
No macro- Macro-
Variable somia somia X2 df E. 
Maternal age < 25 years 330 34 
Maternal age 2. 25 years 215 42 6.24 1 <0.25 
Primigravida 162 18 
Multigravida 383 58 0.91 1 ns 
Obese 464 54 
Not obese 70 20 8.91 1 <0.03 
No excessive weight gain 294 19 
Excessive weight gain 243 57 22.40 1 (0.01 
No current pregnancy 
complications 470 59 
Current pregnancy 
complications 75 17 3.26 1 ns 
Negative one-hour test 384 49 
Positive one-hour test 98 18 1.14 1 ns 
Negati ve three -hour OGTT 76 16 
Positive three-hour OGTT 5 2 0.05 1 ns 
Negative diabetic family history 319 46 
Positive diabetic family history 226 30 0.04 1 ns 
Positive past obstet. outcome 233 42 
Negative past obstet. outcome 108 16 0.43 1 ns 
No past pregnancy complica. 303 49 
Past pregnancy complications 38 8 0.17 1 ns 
No past big baby 302 36 
Past big baby 39 21 22.68 1 <0.01 
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had no excessive weight gain were large. It is interesting that there was no 
association between excessive weight at the beginning of pregnancy and 
excessive weight during the pregnancy. The best predictor of macrosomia 
appears to be a history of previous large infants. Thirty -five percent of all 
women with a history of bearing one or more infants that weighed more than 
4000 grams had another large baby. Only about 11 percent of the other 
multigravidas had a large baby. 
CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
Since all the patients in this study did not receive a three-hour OGTT, 
the true number of gestational diabetics in this population is not known. 
Thus, the sensitivity (the percent correctly identified; number discovered/ 
total number) and selectivity (percent correctly excluded; number excluded/ 
number true negatives) of neither the traditional screening test nor the one-
hour glucose screening test can be determined. However, the fact that within 
the subpopulation that received a three-hour OGTT two more gestational dia-
betics were identified by the one -hour screening test than by the use of tradi-
tional screening factors suggests that the one-hour test is the more efficient 
screening tool. There is no reason to believe that this result is biased by 
a nonrandom selection of patients who received the screening test because 
the group who had a three -hour OaTT did not differ from the remainder of 
the population in any variables except gestational age and birthweight of their 
infants. The women who did not receive the screening test tended to deliver 
about a week and a half ear Her and their babies were about 200 grams 
lighter. This probably reflects the fact that they received less prenatal 
care than did the other mothers and seems unlikely to be related to any 
tendency to develop gestational diabetes. 
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The results of this study support the assertion of O'Sullivan et ale 
(1973) that the age of the prenatal patient is an important factor in the iqenti-
fication of gestational diabetes. All seven of the identified gestational dia-
betics were 25 years old or older. O'Sullivan and his colleagues report that 
84 percent of the gestational diabetics in their population was at least 25 years 
old. 
A comparison of the distribution of traditional screening factors in 
this study and that of O'Sullivan et al. (1973) is presented in Table 9. A 
significantly higher proportion of the patients at the Family Health Program 
clinics had traditional screening factors present than did those in O'Sullivan's 
study (X2 = 58.26; df = 2;.E = 0.001). O'Sullivan's group found that 2.5 perr-
cent of their population was gestational diabetics. There was a 1.1 percent 
yield of gestational diabetics in this study. The difference in the proportion 
of identified gestational diabetics in the two studies is not significant (X2 = 
0.22; df = 1; .e. < 0.05), despite the fact that all the gestational diabetics were 
Table 9 
Comparison of the Distribution of Traditional Screening 
Factors in This Study Population and in the Population 
Studied by O'Sullivan et al. (1973) 
No TSF present 1 TSF present 2 TSF present 
O'Sullivan's patients 10, 534 (56%) 5,882 (31%) 2,446 (13%) 
F • H.P. patients 256 (41%) 271 (43%) 103 (16%) 
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identified in their study (See Table 10). Amanhwak (1977) reported that 6 
percent of his 1184 patients were identifie~ as gestational diabetics. This 
is a surprisingly high figure since the United States national average for 
diabetes is only about 5 percent according to the most recent National Insti-
tutes of Health report (1978). One would expect a much lower incidence of 
the early, transient form of this disease. One explanation for their higher 
percentage is the unusually low cut-off blood sugar values they used for 
their three-hour OGTT. By definition the diagnosis of gestational diabetes 
is established when two or more predetermined blood sugar levels are met or 
exceeded resulting in a positive OGTT. The number of positive tests and 
consequently the number of identified gestational diabetics is therefore 
inversely proportional to the values set as the "cut-off" blood sugar levels. 
The three-hour cut-off values suggested by O'Sullivan and Mahan (1964) are 
well-accepted and are used when Somogyi-Nelson determinations are made 
using venous whole blood. When plasma rather than whole blood is used 
Table 10 
Comparison of the Diabetic and Nondiabetic PopUlations in the 
O'Sullivan et ale (1973) Study and the F. H. P. Centers 
O'Sullivan's patients 










O'Sullivan and Kantor (1963) suggest increasing the three-hour values by 
12 percent. Niejadlik, Dube, and Adamko (1973) suggest increasing these 
values by 13 percent. Amankwah (1977) used even a slightly smaller modifi-
cation. The F. H. P. clinics use the blood sugar levels suggested by 0 'Sullivan 
and his colleagues and increase them by 15 percent, rounded to the nearest 
whole value, for plasma (except for an anomalously low three-hour value 
that was only increased by 10 percent). These various cut-off values are 
presented in Table 11. I was unable to discover the rational underlying the 
decision at F. H. P. to use the 15 percent modification. In the present instance, 
had the 13 or 14 percent modifications been used there would have been no 
change in the number of gestational diab~tics identified. Had Amankwah' s 
low cut-off values been used one more patient would have been identified as a 
bestational diabetic. 
Table 11 
Values Used as Cut-offs on the Three-hour OGTT 
O'Sullivana A mankwahO 
l3%b b (1964) (1976) 14%b 15%b F. H. P. 
Fasting 90 100 (11.1%) 101.7 102.6 103.5 104 
One-hour 165 180 ( 9.1%) 186.5 188.1 189~8 190 
Two-hour 145 160 (10.3%) 180.8 165.3 166.8 167 
Three-hour 125 140 (12.0%) 141.3 142.5 143.8 138 
aValues for whole blood. 
by alues for blood plasma. 
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Estimation of the True Number of Gestational Diabetics 
Out of 531 patients screened with a one-hour blood sugar test, 7 gesta-
tional diabetics were eventually identified. Another patient with a past history 
of gestational diabetes had a very positive one -hour screening test and an in-
conclusive three -hour OGTT. The three -hour test was aborted after a nega-
tive fasting level and a very high positive one -hour value had been determined 
because the patient began vomiting. This woman was not included among the 
diabetics although she was a likely candidate for inclusion. Therefore, there 
were 7 (and possibly 8) gestational diabetics (GO) identified in a population of 
531 patients using a screening test which has an estimated sensitivity of 79 
percent (OtSullivan et al., 1973). Another two patients can be assumed to be 
present but undiagnosed. Nine to 10 true gestational diabetics in this group of 
531 patients would extrapolate to 10 to 12 gestational diabetics for the 630 
patients in the study population. Thus, if all 630 patients had received a three-
hour OGTT, 10 to 12 patients would probably have been identified as diabetic. 
This would be an incidence of 1.6 to 1.9 percent compared to the 1.1 percent 
actually discovered in the population. If slightly lower values were used for 
the three -hour OGTT there would, of course, tend to be an increase in the 
incidence of identified gestational diabetes. 
7 -8 GD tV 79% of all # 9-10 GO 
531 patients GO present' 531 patients 






At the Family Health Program of Utah a one-hour blood sugar screen-
ing test, according to the director of their laboratory. costs approximately 
$4.30 per test and a three -hour OGTT $7 .30 per test. If all 630 patients in 
this study had received a three-hour OGTT and 10 to 12 gestational diabetics 
had been identified, the cost of identifying each diabetic would have been 
$460 to $383. If all 630 patients had received a one -hour screening test and 
the same proportion of positives occurred as was found in this study (22%), 
139 patients would have required a three-hour OGTT. An estimated 9 to 10 
gestational diabetics would have been identified. The cost per identified gesta-
tional diabetic in this case would be $415 to $374. Using a screening test the 
clinic saved $861 (23%), but identified an estimated 21 percent fewer dia-
betics than if the three-hour OGTT was routinely given (Table 12). 
Though the cost of a procedure -is often a major consideration in deter-
mining its use in any institution, it is generally not the only one. The advan-
tages of giving every patient a three-hour OGTT is its 100% effectiveness in 
identifying all gestational diabetics within a given population and possibly its 
improved patient compliance, since they need only come for one rather than 
possibly two blood sugar tests. The advantage of using a one-hour screening 
test is that the majority of the patients will need to take a single shorter 
test. The overall laboratory costs will be less, though the cost per identified 
gestational diabetic mayor may not be. Clearly each institution must weigh 
Table 12 
Comparison of Laboratory Costs Involved in Various 
Methods of Screening for Gestational Diabetes 
Number Cost Number Cost Number of 
Patients One -hour Patients Three-hour Total Gestational 












630 $4599 $4599 
139 $1029 $3738 
100 $ 724 $3007 
630 $4599 $7308 
aLine 1: Cost of giving all patients in this study a three-hour OGIT. 
10 - 12 $460 - $383 
9 - 10 $415 - $374 
7 $429 
10 - 12 $731 - $609 
bLine 2: Estimated cost to screen with a one-hour blood sugar test in this study if patient compliance 
had been 100%. 
CLine 3: Actual laboratory cost for use of one-hour glucose screening in this study. 
d Line 4: Estimated laboratory cost for proposed research project to determine efficacy of one-hour screening 




these factors against their own resources, goals and the needs and character-
istics of their particular patient populations in deciding what method to use 
to identify gestational diabetes. 
CHAPTER V 
CONCLUSIONS AND RECOMl\tfENDATIONS 
The main purpose of this study was to determine whether a one -hour 
blood sugar screening test is a more effective screening tool for identifying 
gestational diabetics than a test based on traditional screening factors. Of 
those patients who had a positive one-hour screening test two more gestational 
diabetics were identified by the one-hour screening test than by a test based 
on traditional factors. 
Ma ternal age was also found to be an important factor in the identifica-
tion of gestational diabetes. All seven identified gestational diabetics were 25 
years old or older. 
It is often thought that macrosomia is more likely among infants of 
gestational diabetics, and this is one of the reasons why practitioners try to 
identify the disease. In this study two of the six singleton births to gestational 
diabetics were infants larger than 4000 grams. However, this was not a sig-
nificantly larger proportion of large infants than found in the population as a 
whole. A significant association \vas found to exist between macrosomia and 
maternal obesity, a weight gain of 30 or more pounds during pregnancy, and a 
maternal age of 25 years or more. 
As a result of its retrospective design there were several problems 
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. 
and limitations in this study. Patients could not be randomly assigned to 
experimental groups. Rather, in large part the patients themselves decided 
whether they did or did not have a one-hour or three-hour OGTT. Because 
only positive one-hour patients generally received a three-hour OGTT, the 
hypothesis that the one-hour screening test does indeed increase the yield of 
identified gestational diabetics could only be tested using a subpopulation and 
the true incidence of gestational diabetes within this patient population could 
only be estimated. The selectivity and sensitivity of the one-hour screening 
test could not be determined. Since the collection of data was limited to a 
chart review the problems of biased charting and incomplete records were 
present. Due to time limitation information regarding the infant was essen-
tially limited to birthweight and gestational age. Many interesting questions 
regarding the outcome of the current pregnancy could not be asked. 
The results of this study suggest several recommendations for further 
study. A prospective study of one to two years duration could be initiated 
in which all F. H. P. patients received both a one-hour screening test and 
a three-hour OGTT. The additional lab work would cost about $3,570 (Table 
12). An alternative would be to have al1 patients of a predetermined random 
subsample of an appropriate sample size receive both tests. In addition to 
the information col1ected in the present study more detailed information should 
be obtained regarding infant outcome, such as morbidity/mortality rates, 
presence or absence of congenital abnormalities, appgar scores and dextro-
stick determinations. The results of the proposed study would provide a 
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definitive determination of the effectiveness of the various screening tests 
for gestational diabetes and of the true incidence of this disease within the 
clinic's population. Also, by obtaining information regarding maternal and 
infant outcome one could compare the results of treatment with those reported 
in the literature, and one would have a baseline against which to judge any 
changes in treatment that may be instituted in the future. 
APPENDIX 
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Glucose Tolerance Test Diet 
(150 grams carbohydrate) 
1. Instructions: 
A. Follow this diet for three days prior to day of test. 
B. On morning of test, do not eat or drink after midnight (except water) 
until test is completed. 
c. The purpose of the diet is to consume 150 grams of carbohydrates 
per day. In order to accomplish this, the diet requires an in-
creased intake of starchy foods, sugar and sweets. Eat or drink 
at least what the diet calls for. More food or liquids may be con-
sumed. 
D. If certain foods or beverages listed on the diet are disliked, substi-
tutions may be made by using the substitution list. Be sure, how-
ever, that the foods exchanged have the same carbohydrate value 
as the foods or beverages that are substituted. 
2. Diet: 
Breakfast 
1 glass (4 ounces) orange juice* 
Eggs and meats, as desired 
1 slice toast* 
1 bowl cereal * 
Butter or margarine, as desired 
4 ounces milk (whole or skim)* 
Coffee, tea as desired 
2 teaspoons sugar (or 2 packages)* 
Lunch 








or 1 Hamburger on bun* 30 
1 glass (8 ounces) milk (whole or skim)* 12 
1 serving fresh fruit* 10 
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*Type of food which ~ be eaten. 
Dinner 
Meat or fish, as desired 
1 serving (1/2 c) potatoes, rice or 
noodles * 
1 s lice bread * 
Vegetables, as desired 
Salad and dressing, as desired 
1 serving fruit flavored gelatin* 
Coffee, tea as desired 
Substitution List: 
Beverages 





Chocolate milk, 1 glass (8 ounces) 25 
Carbonated beverages, 1 can (12 ounces 
non-dietary) 40 
Fruit juice, 1 glass (4 ounces) (except 
vegetable or tomato juice) 10 
Breakfast Foods 
Doughnut or muffin, 1 each 
French toast or pancake, 1 each 
Syrup, 1 tablespoon 
Dinner Foods 
Hot roll, 1 each 
Cornbread, 1 square 
Dried beans or peas, cooked, 1/2 cup 
Corn on the cob, 1 each 
Corn, kernels, 1/2 cup 
Hot dog bun, 1 each 
Hamburger bun, 1 each 
Pizza, 1/8 of large pizza 
Desserts 
Cake, 1 serving 
Pudding, 1/2 cup 
Sherbet, 1/2 cup 
Brownie, 1 each 
Banana, 1 medium 
Miscellaneous 
Popcorn, 1 cup 
Chocolate candy, 1 ounce 






















REAGENT FOR THE DETERMINATION OF GLUCOSE 
Product No. 86247, 89017, and 89019 
A. Product Uses 
'Spin Chern' Glucose Reagent is an enzymatic end point procedure for the in 
vitro quantitative assay of glucose. It is easily performed manually within 
5 minutes, and has been adapted to many automated analyzers. Specific 
instrument instruction"s are available from SmithKline. 
B. Test Summary 
Elevated serum glucose levels (hyperglycemia) occur with diabetes, infection, 
hyperthyroidism, or uremia. Depressed glucose levels (hypoglycemia) are 
associated with over-administration of insulin or other antidiabetic medication, 
or diseases of the pituitary or adrenal glands. Searcylgives an exhaus tive list 
of factors, both physiological and pathological, which may alter circulating 
glucose levels. 
Elevated urine glucose levels are associated with many of the states which 
produce hyperglycemia, while depressed urine glucose levels indicate urinary 
tract infection. CSF glucose levels are generally 70% of serum glucose levels .. 
In bacterial infections of the CNS, however, CSF glucose levels may be sig-
nificantly depressed. 
The 'SPIN CHEM' Glucose Reagent is formulated to determine glucose in body 
fluids by a modification of the Barthelmai and Czok2 procedure which employs 
HK and G-6-PD. 
SmithKline has made mcxiifications which speed completion of the reaction and 
eliminate the need for deproteinization of the sample. Substitution of NAD 
for NADP reduces reagent cost. 
Abbreviations: ADP (adenoisine diphosphate); ATP (adenosine triphosphate); 
CNS (central nervous system); CSF (cerebrospinal fluid); G-6 -P (glucose-6-
phosphate); G-6-PD (G-6-P dehydrogenase); HK (hexokinase); NAD (nicotina-
mide adenine dinocleotide); NADH2 (NAD, reduced); NADP (NAD phosphate); 
UIL (International Enzyme Unit). 
C. Test Principles 
glucose + ATP ___ ~> G-6-P+ADP 
G-6-P+ NAD ---.",.> 6-phosphogluconate + NADH2 
The reaction is initiated by the addition of patient sample to the reagent. 
Although hexokinase reacts slightly with other hexose sugars, the assay 
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is specific for glucose due to the high specificity of G-6 -PD for G-6 -P. 
Specificity is such that fructose, galactose, and mannose give activity less 
than 1% of that induced by an equivalent quantity of glucose. 
An increase in absorbance at 334, 340, or 365 nm due to the formation of 
NADH2 is directly proportional to the glucose concentration of the sample. 
D. Reagent Composition 
Concentration of reagent in final reaction mixture: ATP: 800.ll M; NAD 830 p M; 
Mg2+: 3 mM; KH (yeast): 700 U/L; G-6-PD (microbial): 1100 U/L. Buffer 
pH 7.5 -:t. 0.1): Piperazine-N, N1-bis (2-ethaneosulfonic acid): 50 mM; sodium 
carbonate: 30 mM. 
In addition to the ingredients specifically listed, the reagent contains a filler, 
a binder, and. enzyme stabilizers. 
E. Precautions for Users 
For in vitro diagnostic use. When used as directed, 'SPIl\1 CHEM' Glucose 
Reagent presents no hazard to the user. 
F. Reagent Preparation and Stability 
Store unopened reagent at 20 to 80 C; protect from light; do not freeze. Note 
expiration date stamped on product. Reagent stability cannot be guaranteed if 
transferred from the original container. Reconstitute each vial with 50 ml 
(Product No. 86247), 20 ml (Product No. 89017), or 6.5 ml (Product 89019) of 
distilled or deionized water, unless stated differently in a specific instrument 
application. If solution becomes turbid it must be discarded. Reconstituted 
reagent is stable 96 hours at 20 to 80 C. or 24 hours at 200 to 250 C. 
G. Sample 
Unhemolyzed serum, plasma, urine, or CSF. Sample preservatives are not 
necessary. Urine or CSF may be analyzed without pretreatment. Urine 
samples should be approximately five times the volume of the usual serum 
sample and should be assayed with a sample blank. Protein-free filtrates 
and similar solutions may also be assayed if they do not contain material 
which inhibits the reagent enzymes. Store samples at 20 to 8°C. 
H. Interfering Substances 
Although anticoagulants and pr~servatives, such as fluoride, in commonly 
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used concentrations do not interfere with this assay, abnormally high levels 
may prolong the time necessary to complete the reaction. If heparin is used 
but is not completely dissolved in sample, reagent addition may cause pre-
cipitation (cloudiness). Standards which contain sulfhydryl binding agents 
as preservatives, such as thimerosal, inhibit the assay reactions. Since the 
reaction is not dependent on glucose oxidase, uric acid and ascorbic acid do 
not interfere. Young, ~ al3 give a comprehensive list of drugs and other 
substances known to alter the circulating glucose levels. 
The average sample blank for 112 hospital patient specimens was 4.3 mg/dl 
measured as glucose. If maximum accuracy is desired, or if serum is 
hemolyzed, icteric, or lipemic, a sample blank must be run. For most 
specimens this sample blank correction is not significant, and therefore not 
required. 
I. Procedural Instructions 
For the following manual assay procedure, suitable glassware, timer, and a 
UV spectrophotometer are required along with the 'SPIN CHEM' Glucose Reagent, 
aqueous glucose standards (50, 100, and 300 mg/dl), and control sera. 
If sample is hemolyzed, icteric, or lipemic a sample blank V?"ill be neces sary . 
Assay 
1. vVavelength: 340 nm. Temperature: within 200 to 370 C. 
2. Mark cuvettes for sample(s), control(s), standard(s), and a sample 
blank (if used). 
3. Pipet into each cuvette: reagent, 1.5 mI. (Substitute saline in any 
sample blank.) 
4. Bring cuvettes to reaction temperature. 
5. Record initial absorbance, A of each cuvette. 
6. Add: serum or plasma, control serum, or standard, "10.u1. 
7. After 5 minutes record the final absorbance, Af • 
If the difference between Af and Ai is greater than 1.7 for a sample, dilute 
1:10 with saline and repeat the assay. 
See Section K for calculations. 
J. Calibration and Quality Control 
Valid results depend upon an accurately calibrated instrument. Consult the 
instrument operating manual. 
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Include standards in every run; glucose standards containing benzoic acid 
or sodium benzoate are suitable (see Section H). Assay standards to deter-
mine calculation factors. Establish a new calibration curve routinely. 
Standards with values in "either mg/dl or millimoles/liter may be used. 
TARGETTM Normal and Abnormal Control Sera (Proouct No. 83001 and 
83201 respectively), which have been assayed in our laboratory, are recom-
mended to routinely check the precision and accuracy of the assay system. 
Satisfactory performance limits are included with these products. 
The capacity of the reagent is 750 mg/dl with the manual procedure given 
in Section 1. Specific instrument instructions list other values. 
K. Calculations 
One mmole of NADH2 is produced for each nmole of glucose present. 
Sample concentration (mg/dl) = IJ. Asample x F 
To calculate a factor (F) a standard must be run with this assay. Determine 
ll. Astandard = Ai. Then F = standard (mg/dl or millimoles/liter)-:-
A standard • If more than one standard is run, calculate the average F. 
Determine II Asample = Af - Ai. If a sample blank was run, subtract 
.6. Ablank from A Asample. If sample was diluted 1:10, multiply final 
value by 10. Millimoles/liter = 0.0556 x mg/dl. 
Example calculation: Absorbance of standard (200 mg/dl): Ai = 0.103, Af = 
0.563, ~ Astandard = 0.460. F = 200 mg/dl+ 0.460 = 435. Absorbance 
of sample blank: 0.018. Af (sample minus blank) = 0.267 - 0.018 = 0.249. 
~ A 1 = 0.249 - 0.090 = 0.159. Sample concentration = 0.159 x 435 = Simp e 69 mg dl. 
L. Procedural Limitations 
With the manual procedure in Section I, the response of the reagent is not 
linear for samples with a concentration greater than 750 mg/dl (A A = 1.7 
at 340 nm). Specific instrument instructions may list other values. 
Results may not be valid if determined more than 30 minutes after the reac-
tion has begun. 
Young et al3 list drugs and other substances which interfere with this test. 
Please refer to Section H for additional information on interfering substances. 
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M. Expected Values 
The normal range was established from the serum of 112 donors screened 
for normality with an automated neocuproine method. 4 The va lues obtatned 
showed a 2 S.D. spread of: 65-105 mg/dl or 3.61-5.83 mmoles/l (corrected 
for blank) and 69-109 mg/dl or 3.83-6.05 mmoles/1 (blank omitted). 
N. Performance 
Precision: The following precision data resulted from repeated analysis 
using the procedure in Section I. Analysis of serum pools over a 10-day 
period: 99:t 3.9 mg/dl (C. V. = 3. 6%), n = 20 (2 assays per day). 
Sensitivity: The sensitivity of this assay is such that 0.23A = 100 mg/dl 
using the procedure described. Correlation: Results obtained with 'SPIN 
CHEM' Glucose Reagent in the assay of 98 samples showed a correlation 
coefficient (r) > 0.97 when compared to results found by assaying the 
same samples Wi th a ferro -ferricyanide method. 5 
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